Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Development of Epigenetic Clocks to Predict Ovarian Aging and Live Birth Rate in Assisted Reproduction Technology Procedures

Authors not listed

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · 2025

Abstract

Epigenetic clocks based on DNA methylation estimate biological age and are associated with age-related conditions, but they have not been validated for female fertility. This prospective, multicenter, observational, non-profit cohort study investigated whether epigenetic age, estimated from peripheral blood DNA methylation, differs between women undergoing in vitro fertilization (IVF/ICSI) who achieve a live birth and those who do not. In a predefined subgroup of 30 women under 40 years of age, epigenetic age was also assessed after ovarian stimulation. Participation did not change clinical management.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-30 MST

Cite this

APA
Anonymous. (2025). Development of Epigenetic Clocks to Predict Ovarian Aging and Live Birth Rate in Assisted Reproduction Technology Procedures. <em>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</em>. https://clinicaltrials.gov/study/NCT07875140
Vancouver
Anonymous. Development of Epigenetic Clocks to Predict Ovarian Aging and Live Birth Rate in Assisted Reproduction Technology Procedures. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. 2025.
BibTeX
@misc{anon2025Develo, title = {Development of Epigenetic Clocks to Predict Ovarian Aging and Live Birth Rate in Assisted Reproduction Technology Procedures}, author = {Anonymous}, journal = {Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings